News & Events

The MIVO® platform offers a next-generation approach to skin absorption assays, combining multi-chamber fluidics with 3D skin models. It accurately mimics in vivo permeation kinetics and capillary circulation, providing highly predictive results for pharmacological, cosmetic, and regulatory studies.

MIVO® gut-on-chip technology provides a robust and physiologically relevant in vitro system for intestinal permeability testing, allowing simultaneous assessment of absorption, transport, and barrier function under conditions that closely mimic the human intestine.

PRESSURE, a Horizon Europe Marie Skłodowska-Curie Actions Doctoral Network, unites leading European experts to tackle therapy resistance in esophageal adenocarcinoma (EAC). By integrating omics data, patient response profiles, and advanced EAC models, PRESSURE aims to develop optimized treatments and train a new generation of researchers to revolutionize cancer therapy.

Combining 3D cell cultures with dynamic perfusion, MIVO® provides a human-relevant platform for investigating drug efficacy, toxicity, and immune responses.
It simulates human tissue interactions, enabling more accurate drug testing and mechanistic studies while reducing reliance on animal models.

Recognized among the 100 Italian Excellences, React4life stands out for its continuous contribution to scientific innovation and commitment to advancing organ-on-chip technologies that redefine preclinical research standards

The meeting represents a milestone for Italy’s stem cell community, strengthening scientific networks and fostering dialogue on innovation, translational research, and the ethical and technological frontiers of regenerative medicine.

Organized by the European Association for Cancer Research, the conference brings together experts investigating cancer biology through next-generation 3D and in vivo models, advancing understanding of tumor mechanics, cellular interactions, and molecular regulation of cancer progression.

B2B, an EU-funded project coordinated by Silvia Scaglione (CNR and React4Life), has successfully developed a pioneering 3D organ-on-chip model of spontaneous breast cancer metastasis to bone. This innovative Breast-to-Bone (B2B) device recreates physiological interactions between cancer and bone tissues, advancing research and accelerating drug discovery against metastatic breast cancer

The MPS World Summit returns for its second edition in Berlin, uniting scientists and stakeholders from around the world to explore advances in organ-on-chip and human-relevant models, driving forward innovation in biomedical and regulatory science.